Incannex Healthcare Inc. (IXHL)
NASDAQ: IXHL · Real-Time Price · USD
0.6800
+0.0035 (0.52%)
At close: Apr 1, 2025, 4:00 PM
0.6346
-0.0454 (-6.68%)
After-hours: Apr 1, 2025, 4:40 PM EDT
Incannex Healthcare Employees
Incannex Healthcare had 9 employees as of June 30, 2024. The number of employees increased by 6 or 200.00% compared to the previous year.
Employees
9
Change
6
Growth
200.00%
Revenue / Employee
$10,889
Profits / Employee
-$2,644,889
Market Cap
18.73M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Jun 30, 2024 | 9 | 6 | 200.00% |
| Jun 30, 2021 | 3 | 1 | 50.00% |
| Jun 30, 2020 | 2 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
IXHL News
- 25 days ago - Incannex Healthcare Inc. Announces Pricing of $12.5 Million Private Placement Priced at the Market Under Nasdaq Rules - GlobeNewsWire
- 5 weeks ago - Stonegate Updates Coverage on Incannex Healthcare Inc. (IXHL) 2Q 2025 - Newsfile Corp
- 6 weeks ago - Incannex Healthcare Inc. Reports Fiscal Second Quarter 2025 Financial Results and Business Updates - GlobeNewsWire
- 2 months ago - Incannex Healthcare Appoints Alison Wimms, Ph.D. to Newly Formed IHL-42X Obstructive Sleep Apnea (OSA) Clinical Advisory Board - GlobeNewsWire
- 2 months ago - Incannex Healthcare Announces Positive Topline Results from Pharmacokinetics (PK) Study of IHL-42X, an Oral Combination Medicine for the Treatment of Obstructive Sleep Apnea - GlobeNewsWire
- 4 months ago - Stonegate Updates Coverage on Incannex Healthcare Inc. (IXHL) 1Q 2025 - Newsfile Corp
- 4 months ago - Incannex Healthcare Inc. Reports Fiscal First Quarter 2025 Financial Results and Business Updates - GlobeNewsWire
- 5 months ago - Incannex Announces Appointment of Dr. Lou Barbato as Chief Medical Officer - GlobeNewsWire